Genzyme, a Sanofi company, on Friday announced that the Food and Drug Administration approved Lemtrada (alemtuzumab) for the treatment of patients with relapsing forms of multiple sclerosis.
The Irish High Court has approved Perrigo's pending acquisition of Irish drug maker Elan, the companies said Friday.
U.S.-based drug maker Perrigo Co. will buy Ireland's Elan Corp. for $8.6 billion, the companies said.
The Food and Drug Administration has approved a new treatment for multiple sclerosis made by Biogen Idec, the agency said.
Early detection of a deadly brain infection that sometimes arises due to treatment of autoimmune disorders with immune-suppressing biotech drugs may improve survival, according to a new study.
A privately owned drug maker in New York is offering $6.5 billion for Irish drug maker Elan Corp., but hasn't heard back from it, according to published reports.
Elan will sell the rights to its drug for multiple sclerosis to partnering company Biogen Idec for $3.25 billion plus royalties, the Irish drug maker said.
The drug market for Crohn's disease treatments will see moderate growth over the next decade,...
Swiss drug maker Biogen Idec and Irish drug maker Elan Corp. have started enrolling patients...
Most consumers may not know a lot about biosimilar equivalence, immunogenicity or what “monoclonal antibody”...